美国 · SEC FORM 4
ROCKWELL MEDICAL, INC.
RMTI · Nasdaq · CIK 0001041024 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
11 同一窗口内观察到的 Form 4 交易行
1 sales · 10 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 4 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-04-11 · Irrevocable Larson Family Investment Trust.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 70,807
- 上期报告
- 89,869
- 日均成交量
- 19,935
- 回补天数
- 3.5
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-04-11 | Irrevocable Larson Family Investment Trust | 买入 (P) | Common Stock | 22,500 | USD 1.08 | USD 24,365 | SEC 申报 ↗ |
| 2025-04-10 | Irrevocable Larson Family Investment Trust | 买入 (P) | Common Stock | 43,000 | USD 1.08 | USD 46,250 | SEC 申报 ↗ |
| 2020-06-30 | Curfman Matthew J.; RBI OPPORTUNITIES FUND II, LLC; RBI OPPORTUNITIES FUND, LLC; RBI PI Manager, LLC; RBI Private Investment I, LLC; RBI Private Investment II, LLC; Richmond Brothers 401(k) Profit Sharing Plan; Richmond Brothers, Inc.; Richmond David S. | 买入 (P) | Common Stock | 24,681 | USD 1.93 | USD 47,563 | SEC 申报 ↗ |
| 2020-05-14 | ELLISON RUSSELL H | 买入 (P) | Common Stock | 2,000 | USD 2.08 | USD 4,160 | SEC 申报 ↗ |
Form 4 申报证据
20 transaction lines in the latest 365-day window; 143 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Strobeck Mark | 卖出 (S) | Common Stock | 1,000 | USD 8.42 | USD 8,420 | SEC 申报 ↗ |
| 2026-07-01 | TIMMINS MEGAN C. | 奖励／授予 (A) | Common Stock | 15,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Strobeck Mark | 奖励／授予 (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (20 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Strobeck Mark | 卖出 (S) | Common Stock | 1,000 | USD 8.42 | USD 8,420 | SEC 申报 ↗ |
| 2026-07-01 | TIMMINS MEGAN C. | 奖励／授予 (A) | Common Stock | 15,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Strobeck Mark | 奖励／授予 (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Radie Robert S | 奖励／授予 (A) | Common Stock | 9,633 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Nissenson Allen | 奖励／授予 (A) | Common Stock | 9,633 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Neri Jesse | 奖励／授予 (A) | Common Stock | 15,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Lau Joan | 奖励／授予 (A) | Common Stock | 9,633 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Hunter Heather | 奖励／授予 (A) | Common Stock | 15,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Dawson Joseph H | 奖励／授予 (A) | Common Stock | 9,633 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Chole Timothy | 奖励／授予 (A) | Common Stock | 15,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | COOPER JOHN G | 奖励／授予 (A) | Common Stock | 9,633 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-14 | TIMMINS MEGAN C. | 代扣税 (F) | Common Stock | 3,667 | USD 0.90 | USD 3,300 | SEC 申报 ↗ |
| 2026-03-14 | Strobeck Mark | 代扣税 (F) | Common Stock | 7,333 | USD 0.90 | USD 6,600 | SEC 申报 ↗ |
| 2026-03-14 | Neri Jesse | 代扣税 (F) | Common Stock | 2,444 | USD 0.90 | USD 2,200 | SEC 申报 ↗ |
| 2026-03-14 | Hunter Heather | 代扣税 (F) | Common Stock | 2,444 | USD 0.90 | USD 2,200 | SEC 申报 ↗ |
| 2026-03-14 | Chole Timothy | 代扣税 (F) | Common Stock | 2,444 | USD 0.90 | USD 2,200 | SEC 申报 ↗ |
| 2026-01-02 | Neri Jesse | 卖出 (S) | Common Stock | 886 | USD 0.84 | USD 744 | SEC 申报 ↗ |
| 2026-01-02 | Hunter Heather | 卖出 (S) | Common Stock | 2,868 | USD 0.84 | USD 2,409 | SEC 申报 ↗ |
| 2025-11-18 | COOPER JOHN G | 卖出 (S) | Common Stock | 5,079 | USD 0.87 | USD 4,419 | SEC 申报 ↗ |
| 2025-11-17 | Dawson Joseph H | 奖励／授予 (A) | Common Stock | 25,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | RMTI |
| CIK | 0001041024 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 143 transaction lines from 2020-01-09 to 2026-10-01 28 P purchase lines · 29 S sale lines · 86 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.